Valuation: Caplin Point Laboratories Limited

Market Cap 193B 2.02B 1.77B 1.63B 1.52B 2.87B 2.92B 19.52B 7.59B 94.73B 7.6B 7.43B 326B P/E 2026
17.9x
P/E 2027 * 27x
Enterprise Value 193B 2.02B 1.77B 1.63B 1.52B 2.87B 2.92B 19.52B 7.59B 94.73B 7.6B 7.43B 326B EV / Sales 2026
5.23x
EV / Sales 2027 * 7.75x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.16%
1 day-0.47%
1 week+1.12%
Current month-3.38%
1 month+28.40%
3 months+61.71%
6 months+37.04%
Current year+37.70%
1 week 2,486.8
Extreme 2486.8
2,680
1 month 2,006.45
Extreme 2006.45
2,680
Current year 1,502.45
Extreme 1502.45
2,680
1 year 1,502.45
Extreme 1502.45
2,680
3 years 782.35
Extreme 782.35
2,680
5 years 575
Extreme 575
2,680
10 years 180
Extreme 180
2,680
Manager TitleAgeSince
Chief Executive Officer 71 2015-03-27
Director of Finance/CFO - 2016-02-18
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 2010-01-26
Director/Board Member - 2025-11-04
Director/Board Member 71 2015-03-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+1.12%+26.64%+213.80% 2.02B
+1.81%+2.25%+13.40%+84.45% 48B
-2.54%+3.72%+65.71%+113.61% 36.89B
+0.15%+1.26%-3.35%+45.56% 12.37B
+3.71%+3.56%+14.13%+97.20% 11.95B
+0.39%+0.58%+33.25%+119.07% 9.01B
+0.66%-0.57%+19.28%+45.55% 7.2B
+0.71%+1.75%+53.59%-7.09% 7.05B
+0.68%+2.63%+23.97%+235.28% 6.55B
+9.99%+32.94%-15.69%+27.08% 6.58B
Average +1.51%+3.93%+23.09%+97.45% 14.76B
Weighted average by Cap. +0.83%+3.32%+27.90%+91.27%

Financials

2026 2027 *
Net sales 21.28B 223M 195M 180M 167M 317M 322M 2.16B 838M 10.46B 839M 821M 36.04B 24.88B 261M 228M 210M 196M 371M 377M 2.52B 980M 12.23B 981M 960M 42.14B
Net income 6.16B 64.72M 56.58M 51.99M 48.46M 91.92M 93.32M 624M 243M 3.03B 243M 238M 10.44B 7.13B 74.86M 65.44M 60.14M 56.06M 106M 108M 722M 281M 3.5B 281M 275M 12.07B
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
26-07-03 ₹2,535.35 -0.47% 18,157
26-07-02 ₹2,547.20 -0.58% 8,483
26-07-01 ₹2,562.15 -2.36% 8,497
26-06-30 ₹2,624.15 +2.57% 40,264
26-06-29 ₹2,558.40 +2.04% 20,602
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,535.35INR
Average target price
2,505.00INR
Spread / Average Target
-1.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAPLIPOINT Stock